Aquinox Pharmaceuticals to Present at the Canaccord Genuity 35th Annual Growth Conference
05 août 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, Aug. 5, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Provide Update on Secondary Endpoints From Phase 2 LEADERSHIP Trial in BPS/IC and Report Second Quarter Financial Results on August 6, 2015
28 juil. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, July 28, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Results From FLAGSHIP Trial With AQX-1125 in Chronic Obstructive Pulmonary Disease Patients With Frequent Exacerbations
09 juil. 2015 08h30 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, July 9, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Results From LEADERSHIP Trial With AQX-1125 in Patients With Bladder Pain Syndrome/Interstitial Cystitis
25 juin 2015 08h30 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, June 25, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Present at 2015 Jefferies Global Healthcare Conference
26 mai 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 26, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces First Quarter 2015 Financial Results
12 mai 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 12, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Completes Enrollment in the Phase 2 KINSHIP Trial of AQX-1125 in Atopic Dermatitis
04 mai 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, May 4, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Present at 2015 Bloom Burton & Co. Healthcare Investor Conference
27 avr. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, April 27, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals to Present at 14th Annual Needham Healthcare Conference
07 avr. 2015 09h15 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, April 7, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Aquinox Pharmaceuticals Announces Year End 2014 Financial Results
16 mars 2015 16h25 HE
|
Neoleukin Therapeutics, Inc.
VANCOUVER, British Columbia, March 16, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. ("Aquinox") (Nasdaq:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...